EXPIRES TOMORROW: Full Transcript of Our Urgent Broadcast on India's Revival
Here is the latest financial fact sheet of Sanofi India. For more details, see the Sanofi India quarterly results and Sanofi India share price and chart. For a sector overview, read our pharmaceuticals sector report.
% ch | % | 0.1 |
No. of shares | m | 23.03 |
% ch week | % | -1.1 |
% ch 1-mth | % | -3.0 |
% ch 12-mth | % | 7.6 |
52 week H/L | Rs | 8,999.0/7,322.1 |
No. of Mths Year Ending |
12 Dec-14 |
12 Dec-15 |
12 Dec-16 |
12 Dec-17 |
12 Dec-18 |
5-Yr Chart Click to enlarge
|
---|
SANOFI INDIA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 3,800 | 4,521 | 4,560 | 4,945 | 6,840 | |
Low | Rs | 2,500 | 3,445 | 4,400 | 3,901 | 4,630 | |
Sales per share (Unadj.) | Rs | 858.7 | 952.3 | 1,028.5 | 1,081.8 | 1,203.1 | |
Earnings per share (Unadj.) | Rs | 114.5 | 139.6 | 132.1 | 141.6 | 165.3 | |
Diluted earnings per share | Rs | 114.5 | 139.6 | 132.1 | 141.6 | 165.3 | |
Cash flow per share (Unadj.) | Rs | 156.4 | 188.7 | 183.7 | 185.9 | 209.9 | |
Dividends per share (Unadj.) | Rs | 45.00 | 65.00 | 68.00 | 71.00 | 84.00 | |
Adj. dividends per share | Rs | 45.00 | 65.00 | 68.00 | 71.00 | 84.00 | |
Dividend yield (eoy) | % | 1.4 | 1.6 | 1.5 | 1.6 | 1.5 | |
Book value per share (Unadj.) | Rs | 645.2 | 706.5 | 753.6 | 879.9 | 963.6 | |
Adj. book value per share | Rs | 645.2 | 706.5 | 753.6 | 879.9 | 963.6 | |
Shares outstanding (eoy) | m | 23.03 | 23.03 | 23.03 | 23.03 | 23.03 | |
Bonus/Rights/Conversions | - | - | - | - | - | ||
Price / Sales ratio | x | 3.7 | 4.2 | 4.4 | 4.1 | 4.8 | |
Avg P/E ratio | x | 27.5 | 28.5 | 33.9 | 31.2 | 34.7 | |
P/CF ratio (eoy) | x | 20.1 | 21.1 | 24.4 | 23.8 | 27.3 | |
Price / Book Value ratio | x | 4.9 | 5.6 | 5.9 | 5.0 | 6.0 | |
Dividend payout | % | 39.3 | 46.6 | 51.5 | 50.2 | 50.8 | |
Avg Mkt Cap | Rs m | 72,545 | 91,724 | 103,174 | 101,862 | 132,078 | |
No. of employees | `000 | 3.4 | 3.7 | 3.6 | 3.2 | 3.3 | |
Total wages/salary | Rs m | 2,882 | 3,333 | 3,553 | 3,685 | 4,068 | |
Avg. sales/employee | Rs Th | 5,735.2 | 5,987.0 | 6,537.7 | 7,691.9 | 8,393.8 | |
Avg. wages/employee | Rs Th | 836.0 | 909.9 | 980.7 | 1,137.7 | 1,232.4 | |
Avg. net profit/employee | Rs Th | 764.5 | 877.7 | 839.6 | 1,006.5 | 1,153.0 |
SANOFI INDIA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 19,775 | 21,930 | 23,686 | 24,914 | 27,708 | |
Other income | Rs m | 643 | 514 | 664 | 807 | 897 | |
Total revenues | Rs m | 20,418 | 22,444 | 24,350 | 25,721 | 28,605 | |
Gross profit | Rs m | 3,389 | 4,591 | 5,351 | 5,372 | 6,235 | |
Depreciation | Rs m | 966 | 1,130 | 1,188 | 1,022 | 1,027 | |
Interest | Rs m | 5 | 4 | 23 | 11 | 7 | |
Profit before tax | Rs m | 3,061 | 3,970 | 4,804 | 5,146 | 6,098 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 666 | 839 | 0 | 0 | 0 | |
Tax | Rs m | 1,090 | 1,594 | 1,762 | 1,886 | 2,292 | |
Profit after tax | Rs m | 2,636 | 3,215 | 3,042 | 3,260 | 3,806 | |
Gross profit margin | % | 17.1 | 20.9 | 22.6 | 21.6 | 22.5 | |
Effective tax rate | % | 35.6 | 40.1 | 36.7 | 36.6 | 37.6 | |
Net profit margin | % | 13.3 | 14.7 | 12.8 | 13.1 | 13.7 |
SANOFI INDIA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 12,628 | 12,437 | 15,753 | 14,438 | 15,922 | |
Current liabilities | Rs m | 6,558 | 4,945 | 5,021 | 6,017 | 6,235 | |
Net working cap to sales | % | 30.7 | 34.2 | 45.3 | 33.8 | 35.0 | |
Current ratio | x | 1.9 | 2.5 | 3.1 | 2.4 | 2.6 | |
Inventory Days | Days | 88 | 80 | 76 | 61 | 64 | |
Debtors Days | Days | 21 | 24 | 22 | 29 | 21 | |
Net fixed assets | Rs m | 8,582 | 8,771 | 8,098 | 7,991 | 7,539 | |
Share capital | Rs m | 230 | 230 | 230 | 230 | 230 | |
"Free" reserves | Rs m | 14,559 | 16,004 | 17,088 | 20,034 | 21,962 | |
Net worth | Rs m | 14,858 | 16,272 | 17,356 | 20,264 | 22,192 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 22,276 | 24,114 | 25,412 | 27,777 | 29,839 | |
Interest coverage | x | 638.6 | 993.5 | 209.9 | 468.8 | 872.1 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | |
Return on assets | % | 11.9 | 13.3 | 12.1 | 11.8 | 12.8 | |
Return on equity | % | 17.7 | 19.8 | 17.5 | 16.1 | 17.2 | |
Return on capital | % | 25.1 | 29.6 | 27.8 | 25.4 | 27.5 | |
Exports to sales | % | 24.2 | 24.2 | 24.5 | 0 | 0 | |
Imports to sales | % | 36.9 | 26.1 | 28.0 | 0 | 0 | |
Exports (fob) | Rs m | 4,788 | 5,312 | 5,801 | 0 | 0 | |
Imports (cif) | Rs m | 7,298 | 5,720 | 6,627 | 0 | 0 | |
Fx inflow | Rs m | 5,495 | 6,680 | 7,145 | 6,306 | 7,587 | |
Fx outflow | Rs m | 8,045 | 6,587 | 6,846 | 5,257 | 7,145 | |
Net fx | Rs m | -2,550 | 93 | 299 | 1,049 | 442 |
SANOFI INDIA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 2,650 | 2,132 | 3,221 | 4,351 | 3,739 | |
From Investments | Rs m | 613 | 359 | -1,550 | -787 | -731 | |
From Financial Activity | Rs m | -1,217 | -1,470 | -1,802 | -1,884 | -1,972 | |
Net Cashflow | Rs m | 2,046 | 1,021 | -131 | 1,680 | 1,036 |
Share Holding
|
Company Information
|
CHM: Vijay Mallya | COMP SEC: K. Subramani | YEAR OF INC: 1956 | BSE CODE: 500674 | FV (Rs): 10 | DIV YIELD (%): 1.0 |
Read: SANOFI INDIA 2017-18 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: ALEMBIC WOCKHARDT PIRAMAL ENTERPRISES AUROBINDO PHARMA UNICHEM LAB
Compare SANOFI INDIA With: ALEMBIC WOCKHARDT PIRAMAL ENTERPRISES AUROBINDO PHARMA UNICHEM LAB
Compare SANOFI INDIA With: MYLAN (US) ADCOCK INGRAM (S. Africa) ACTAVIS (US) TEVA PHARMA (Israel)
Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.
For the quarter ended September 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 5.0% YoY). Sales on the other hand came in at Rs 7 bn (down 11.9% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.
For the quarter ended June 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 39.9% YoY). Sales on the other hand came in at Rs 7 bn (down 5.0% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.
More Views on NewsAjit Dayal on how India's vaccine strategy will impact the markets.
Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.
Narayana Murthy was one of the first unicorn founders to get the backing of this entity...
In this video, I'll you what I think is the real reason behind yesterday's market crash.
This ignored sector could deliver big short-term profits.
More